People / Staff

Manuel Vázquez Carrera

Search publications

Publications

  • Roglans N, Vilà L, Farré M, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats.

    HEPATOLOGY . 45(3): 778-788. Number of citations: 184

    [doi:10.1002/hep.21499]

  • Coll T, Jové M, Rodríguez-Calvo R, Eyre E, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.

    Diabetes . 55(10): 2779-2787. Number of citations: 125

    [doi:10.2337/db05-1494]

  • Rodríguez-Calvo R, Jové M, Coll T, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.

    PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 61(8): 773-780. Number of citations: 27

    [doi:10.1093/gerona/61.8.773]

  • Planavila A, Rodríguez-Calvo R, de Arriba AF, Sánchez RM, Laguna JC, Merlos M and Vazquez M.

    Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.

    MOLECULAR PHARMACOLOGY . 69(4): 1174-1181. Number of citations: 7

    [doi:10.1124/mol.105.016345]

  • Sanguino E, Roglans N, Rodríguez-Calvo R, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Ageing introduces a complex pattern of changes in several rat brain transcription factors depending on gender and anatomical localization.

    EXPERIMENTAL GERONTOLOGY . 41(4): 372-379. Number of citations: 8

    [doi:10.1016/j.exger.2006.02.011]

  • Llaverias G, Rebollo A, Pou J, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes.

    BIOCHEMICAL PHARMACOLOGY . 71(5): 605-614. Number of citations: 31

    [doi:10.1016/j.bcp.2005.11.022]

  • Jové M, Planavila A, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation.

    Endocrinology . 147(1): 552-561. Number of citations: 141

    [doi:10.1210/en.2005-0440]

  • Planavila A, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1736(2): 120-127. Number of citations: 20

    [doi:10.1016/j.bbalip.2005.08.001]

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.

    BRITISH JOURNAL OF PHARMACOLOGY . 145(7): 853-861. Number of citations: 48

    [doi:10.1038/sj.bjp.0706260]

  • Cabrero A, Cubero M, Llaverías G, Alegret M, Sánchez R, Laguna JC and Vazquez M.

    Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages.

    MOL CELL BIOCHEM . 275(1-2): 173-179. Number of citations: 40

    [doi:10.1007/s11010-005-1353-8]